GGT (Gamma-Glutamyl Transferase)

Blood

Liver Function

GGT (gamma-glutamyl transferase) is a liver enzyme especially sensitive to alcohol and bile duct disease, and it also reflects oxidative stress in the body. A preventive practice tracks GGT as both a liver marker and a broader signal of metabolic strain and long-term risk.

What It Measures

Liver enzyme sensitive to alcohol and bile duct disease; oxidative stress marker and longevity predictor

Optimal vs. Lab Range

Longevity Optimal

<20 U/L (M), <15 U/L (F)

Target range for optimal health and longevity based on research.

Standard Lab

0–65 U/L

Population-based reference range from standard labs.

Why It Matters

GGT is valued in longevity-focused care because it captures more than liver health alone. Elevations can reflect alcohol use, bile duct disease, fatty liver, oxidative stress, or metabolic syndrome, and importantly, an elevated GGT independently predicts cardiovascular mortality, which makes it a meaningful marker even when other liver tests look normal. A low GGT is rarely significant. Because it responds sensitively to alcohol and to the oxidative burden associated with metabolic dysfunction, GGT often serves as an early warning that the body is under strain, and it is read alongside ALT, AST, and uric acid for context.

When Low

Rarely significant when low

When High

Alcohol use, bile duct disease, fatty liver, oxidative stress, metabolic syndrome; elevated GGT independently predicts cardiovascular mortality

How to Optimize

The most impactful step for an elevated GGT is reducing or eliminating alcohol, since the enzyme is highly responsive to it. Supporting liver health and lowering oxidative stress through metabolic optimization, and where appropriate physician-guided antioxidant support such as N-acetylcysteine, can also help bring it down. Because GGT tracks with metabolic syndrome, improving insulin sensitivity and overall metabolic health tends to move it in the right direction. GGT is best interpreted with ALT, AST, ALP, and bilirubin. Targets and treatment are individualized with your physician; this content is educational and not a substitute for medical advice.

Key Interventions & Linked Compounds

Strong evidence

Key Interventions

Alcohol cessation

liver support

NAC

antioxidant support

Linked Compounds & Supplements

NAC

Milk thistle

Glutathione

Alpha-lipoic acid

Curated from clinical literature. Individual results vary; consult a qualified clinician before changing a protocol.

Ordering Notes

Specimen

Serum or plasma (venous draw)

Patient prep

No fasting required. Maintain usual diet and medications unless advised.

Recommended cadence

Annual

Reporting unit

Confirm with the performing lab — units vary by region.

Pre-analytic notes

Standardize draw time of day, hydration, and recent exercise. Note any acute illness, supplements, or hormonal therapies on the requisition.

Recommended Follow-Up Actions

1
Confirm the result is reliable
Repeat abnormal values before acting — preferably from the same lab, same time of day, and under consistent prep. Rule out acute illness, recent intense exercise, or medication effects that can shift GGT (Gamma-Glutamyl Transferase).
2
Compare against optimal, not just lab range
Use the optimal window above as the target. Lab "normal" is built from the general population and often misses early dysfunction.
3
Pair with related markers
Order a complementary panel covering metabolic, inflammatory, and hormonal context to interpret this marker properly.
4
Discuss interventions with a clinician
Use the interpretation guidance above to frame the conversation. Bring trends, not just one datapoint, to your visit.
5
Re-test on a defined cadence
If a change is implemented, re-measure in 8–12 weeks for fast-moving markers, or 3–6 months for slower ones, to confirm response before escalating.